Q4 2022 Holdings
Filed 2023-02-08 | 5 holdings | $273.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Arcellx Inc.(ACLX) | COMMON STOCK | 03940C100 | $170.4M | 5,500,007 | 62.2% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $67.0M | 6,526,476 | 24.4% |
| ARS Pharmaceuticals(SPRY) | COM | 82835W108 | $25.7M | 3,009,677 | 9.4% |
| Nkarta Inc.(NKTX) | COM | 65487U108 | $8.0M | 1,333,333 | 2.9% |
| Effector Therapeutics Inc | COM | 28202V108 | $2.9M | 6,822,114 | 1.1% |